Joseph Bateman retweeted
The #mTOR node symposium brought together researchers, clinicians, people with lived experience and industry partners to discuss research and collaboration within the community.
kcl.ac.uk/news/symposium-bri…
@BatemanLab @RDRUKHub @UKTSA @PTENResearch @The_MRC
#RareDiseaseReseach
Joseph Bateman retweeted
Did you know?
Around 80% of rare conditions arise due to changes in a person's genomic makeup, which can be inherited or arise for the first time in an individual. 🧬
🎙️Hear from mTOR node
@BatemanLab
Joseph Bateman retweeted
MSCA International Training Program MENTOR, European PhD Network focused on mTOR pathophysiology. Apply to one of the 18 open PhD positions!
This Post is from a suspended account. Learn more
Joseph Bateman retweeted
👏🧠A new partnership between @KingsCollegeLon (@BatemanLab) , OxfordStemTech and @mxwbio has received funding from @InnovateUK to create a high-throughput drug testing platform to address limited treatment options for epilepsy
#PrecisionMedicine #iPSC #organoids #Neuroscience
Joseph Bateman retweeted
🧲Ready to make a real difference in research and advocacy?
📡By listening, sharing, and working together, we can better address the challenges faced in rare disease research
🌟Join us for our free webinar on Introduction to Co-Production!
Register now🔗tinyurl.com/yy2af665
Joseph Bateman retweeted
📢Registrations Now Open📢
🌟Join us for our 2nd Hybrid Annual Conference!🌟
💊inspiring keynote speakers 🪩lively panel discussions💥connect with others who are just as passionate about driving progress in rare disease research!
🔗tinyurl.com/RDRUKConf
Joseph Bateman retweeted
Our lab's latest study, spearheaded by a fantastic colleague, Colleen, reveals that the blood glucose-lowering effect of metformin requires the inhibition of mitochondrial ETC complex I. science.org/doi/10.1126/scia….
An insightful focus by Prof. Doug Green: bit.ly/41Hc4fX
Joseph Bateman retweeted
We had a brilliant time attending the mTOR Pathway Diseases node patient organisation workshop last week. Great to hear exciting updates from the #Research team and a great opportunity to connect with other patient orgs @BatemanLab @CharlotteRTye
The excellent @CharlotteRTye led our mTOR Pathway Diseases node patient organisation workshop last week. Thanks to everyone that attended
@UKTSA @GoPI3Ks @ptenuki @LAMAction @myrovlytis @ChildGrowthUK
@EpilepsyInst @OrigamiCells.
Supported by @The_MRC @NIHRresearch @RDRUKHub
Joseph Bateman retweeted
A snippet from our day. I feel privileged to lead #PPI for the mTOR node and to learn so much from our patient organisation partners and lived experience experts- thank you for giving your time and helping our research grow. Watch this space! @KingsIoPPN
The excellent @CharlotteRTye led our mTOR Pathway Diseases node patient organisation workshop last week. Thanks to everyone that attended
@UKTSA @GoPI3Ks @ptenuki @LAMAction @myrovlytis @ChildGrowthUK
@EpilepsyInst @OrigamiCells.
Supported by @The_MRC @NIHRresearch @RDRUKHub
Joseph Bateman retweeted
We have funding from the MND Association for a PhD studentship, starting in September 2025, if interested please see
@FindAPhD
findaphd.com/phds/projectdet…
Joseph Bateman retweeted
📢REGISTRATION NOW OPEN📢
🚨1st EpiGenRare Conference
🗓️26 March 2025
🏢Hyatt Regency, Manchester
Please register your attendance for free using the link or QR code below
buytickets.at/rdrukepigenrar…
@smbanka @RDRUKHub
#RareDisease #rarediseaseresearch
Joseph Bateman retweeted
Incredibly excited to see our recent paper about the auto-regulation of #mTOR at #lysosomes featured on the cover of @MolecularCell 🤩🌍🎈 @DemetriadesLab
Huge thanks to @sahola6 for so beautifully capturing the essence of our story in her artwork😍
👉🏼cell.com/molecular-cell/full…
Joseph Bateman retweeted
Meet iCASE student Mohua! Whilst you hear about what Mohua is researching, this is your reminder that applications for 2025 entry MRC DTP Studentships @KingsCollegeLon will close tomorrow at 13:00 GMT. Have you thought about applying yet?
#MRCDTP25
Joseph Bateman retweeted
If you’ve been a ‘#PPIE’ contributor to #RareDisease research and would recommend the experience – please share this new award with the researchers you know.
👉 ow.ly/Le5K50TmVOS
@RDRUKHub
Joseph Bateman retweeted
1/5. Exciting new insights into Brain Mosaicism & FCDII-associated epilepsy!
2 preprints with single-cell profiling of FCDII:
- Our lab: doi.org/10.21203/rs.3.rs-401… with @SaraBaldassari4 @KlinglerEsther
- @ChrisAWalsh1 lab: doi.org/10.1101/2024.10.01.6… with @sarabiz86 @SattarKhoshkhoo
Joseph Bateman retweeted
📢Young researchers working with people with lived experience hold the key to the future of #rarediseaseresearch!
💥Calling all early career researchers to apply and highlight your research engagement in #PPIE
🔗tinyurl.com/PPIEAward
💫Deadline : 17 Nov 2024
Joseph Bateman retweeted
It landed...
nature.com/immersive/d42859-…
Joseph Bateman retweeted
Want to do a PhD studying neurodevelopmentamdisorders & mTORopathies using iPSCs and brain organoids? Then check out our project with @BatemanLab ! findaphd.com/phds/project/de… @KCL_MRCDTP @KingsIoPPN @MRC_CNDD
Interested in researching neurodevelopmental disorders using iPSCs? Take a look at our iCASE PhD studentship, together with @NCNDgroup_KCL, to study mTORopathies kcl-mrcdtp.com/project/devel…
@KCL_MRCDTP @KingsIoPPN
findaphd.com/phds/project/de…































